Rare diseases
Investigational molecules
Locations
Back to France649 clinical trials in Pierre Benite, France across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)Study on Mosunetuzumab and Lenalidomide for Patients with Untreated Follicular Lymphoma
FranceStudy of Lacutamab Alone or with Chemotherapy for Patients with Advanced T-Cell Lymphoma
FranceStudy of IO102-IO103 and Pembrolizumab for Patients with Advanced Melanoma
FranceStudy of Axi-Cel, Fludarabine Phosphate, and Cyclophosphamide for Patients with Relapsed/Refractory Aggressive B-Cell Non-Hodgkin Lymphoma Ineligible for Stem Cell Transplant
FranceStudy Comparing Ponatinib and Imatinib with Chemotherapy for Patients with Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
FranceStudy Comparing Fedratinib with Drug Combination for Myelofibrosis in Patients Previously Treated with Ruxolitinib
FranceStudy on the Effectiveness and Safety of CAEL-101 with Drug Combination for Patients with Advanced AL Amyloidosis
FranceStudy on the Effectiveness and Safety of Lebrikizumab for Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis
FranceStudy on Niraparib for Maintenance Treatment in Patients with Advanced Ovarian Cancer After Initial Chemotherapy Response
FranceStudy on the Effects of Pasireotide in Patients with Low Blood Sugar After Bariatric Surgery
FranceStudy Comparing Subcutaneous and Intravenous Isatuximab with Pomalidomide and Dexamethasone for Adults with Relapsed or Refractory Multiple Myeloma
FranceStudy on the Safety and Effects of Mosunetuzumab and Lenalidomide for Patients with Follicular Lymphoma
FranceThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on vaccine development against major viral infections. Studies include evaluations of new treatments for influenza, cytomegalovirus, and yellow fever.
Research aims to enhance prevention and protection against these significant viral threats.
Groundbreaking research in inflammatory bowel diseases, exploring innovative therapeutic approaches including fecal microbiota transplantation for both Crohn's disease and ulcerative colitis.
Studies focus on developing alternative treatment strategies for patients with limited therapeutic options.
Comprehensive research into blood cancers and solid tumors, including multiple myeloma, leukemia, and advanced prostate cancer. Trials evaluate novel therapeutic combinations and targeted treatments.
Focus on developing more effective and personalized treatment approaches.
Studies addressing heart failure prevention, chronic kidney disease, and metabolic disorders. Research includes evaluation of novel drug combinations and therapeutic strategies.
Emphasis on preventing disease progression and improving patient outcomes.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
